zweidimensionales bewegtes Bild
Toxic epibatidine was structurally modified to image Alzheimer´s disease
- Standort
-
Hannover TIB
- Umfang
-
229MB, 00:10:07:16 (unknown)
- Sprache
-
Englisch
- Anmerkungen
-
Audiovisuelles Material
- Erschienen in
-
Toxic epibatidine was structurally modified to image Alzheimer´s disease ; (Jan. 2014)
- Schlagwort
-
epibatidine
medicinal
- Ereignis
-
Veröffentlichung
- (wer)
-
Beilstein-Institut zur Förderung der Chemischen Wissenschaften
- (wann)
-
2014-01-01
- Beteiligte Personen und Organisationen
-
Brust, Peter
Scheunemann, Matthias
Franke, Karsten
Wenzel, Barbara
Deuther-Conrad, Winnie
Kranz, Mathias
- DOI
-
10.5446/50371
- Letzte Aktualisierung
-
04.12.2024, 08:09 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Technische Informationsbibliothek (TIB). Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Technische Informationsbibliothek (TIB). Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- zweidimensionales bewegtes Bild
Beteiligte
- Brust, Peter
- Scheunemann, Matthias
- Franke, Karsten
- Wenzel, Barbara
- Deuther-Conrad, Winnie
- Kranz, Mathias
- Beilstein-Institut zur Förderung der Chemischen Wissenschaften
Entstanden
- 2014-01-01
Ähnliche Objekte (12)
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
Medical image classification for Alzheimer’s using a deep learning approach
Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Alzheimer’s Disease
Alzheimer
Alzheimer
Generalvollmacht: Eduard Alzheimer für Karl Alzheimer
Treatments in Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
Medical image classification for Alzheimer’s using a deep learning approach
Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Alzheimer’s Disease
Alzheimer
Alzheimer
Generalvollmacht: Eduard Alzheimer für Karl Alzheimer
Treatments in Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
Medical image classification for Alzheimer’s using a deep learning approach
Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Alzheimer’s Disease
Alzheimer
Alzheimer
Generalvollmacht: Eduard Alzheimer für Karl Alzheimer